JSPL records highest-ever exports of steel in April 2020
JSPL records highest-ever exports of steel in April 2020

JSPL records highest-ever exports of steel in April 2020

Apurva Joshi Article rating: 3.3

Jindal Steel & Power Limited (JSPL) has reported its highest-ever exports of steel & related products during April 2020. It exported 2,48,000 MT of steel & related products, which is a growth of 109 per cent (MoM). Export contributes to 74 per cent of its total sales volume.

CONCOR to surrender 15 terminals to Indian Railways
CONCOR to surrender 15 terminals to Indian Railways

CONCOR to surrender 15 terminals to Indian Railways

Nidhi Jani Article rating: 4.0

This step has been taken due to commercial and business viability considerations. The company has surrendered its 15 terminals, generating a total turnover of Rs 277.50 crore and net worth of Rs 64.84 crore.

Index trend and stocks in action on May 05, 2020
Index trend and stocks in action on May 05, 2020

Index trend and stocks in action on May 05, 2020

Karan Dsij Article rating: 4.0

An immediate support for Nifty is placed around 9,240-9,250 level followed by 20-DMA, which is placed at 9,050. On the upside, an immediate resistance for Nifty is placed at 9,400 mark. Stocks in news: Lupin, ICICI Bank, Colgate-Palmolive, Nath Bio-Genes (India), Container Corporation of India.

‘Terrific Tuesday on the cards today!
‘Terrific Tuesday on the cards today!

‘Terrific Tuesday on the cards today!

Karan Dsij Article rating: 5.0

After a landslide fall in the previous trading session, the market is all set for a rebound on Tuesday, largely led by firm global cues. However, we believe that at higher levels, profit booking could emerge as ICRA has projected 20 per cent GDP contraction in June quarter and two per cent contraction in FY21 overall.

After Facebook, Silver Lake to invest in Reliance Jio
After Facebook, Silver Lake to invest in Reliance Jio

After Facebook, Silver Lake to invest in Reliance Jio

Geyatee Deshpande Article rating: 3.5

Recently, the news about Facebook’s investment in Reliance Jio was well-received by the general public. Following it, Reliance Industries has now announced about rights issue as well of Silver Lake’s investment in Jio.

BHEL invites Global OEMs for Make in India initiative
BHEL invites Global OEMs for Make in India initiative

BHEL invites Global OEMs for Make in India initiative

Anthony Fernandes Article rating: 5.0

On Monday, Bharat Heavy Electricals Limited (BHEL) stated that it had floated an expression of interest, inviting companies from around the world to partner with the public sector power equipment major as well as to set up their manufacturing facilities in the country, in-line with Prime Minister Narendra Modi’s Make in India initiative.  

Panelav facility of Alembic Pharma gets VAI classification
Panelav facility of Alembic Pharma gets VAI classification

Panelav facility of Alembic Pharma gets VAI classification

Anthony Fernandes Article rating: 4.5

The shares of Alembic Pharmaceuticals were trading in green on Monday, defying the market mood after US drug regulator classified the company's Panelav facility as voluntary action indicated (VAI).

Monday mayhem on D-Street
Monday mayhem on D-Street

Monday mayhem on D-Street

Geyatee Deshpande Article rating: 4.3

Last week, Sensex wrapped-up the month of April 2020 on a positive note as the index gained by 19.29 per cent during the month. Post this hype up, on Monday, the domestic benchmark indices witnessed a chaotic session as Sensex sunk by 5.94 per cent, which is 2,002.27 points to reach the level of 31,715.35 while, Nifty dipped by 5.74 per cent which is 566.40 points to 9,293.50 level.

Aurobindo Pharma gets USFDA approval for Flucytosine capsules
Aurobindo Pharma gets USFDA approval for Flucytosine capsules

Aurobindo Pharma gets USFDA approval for Flucytosine capsules

Apurva Joshi Article rating: 5.0

Aurobindo Pharma Limited announced that it has received a final approval from US Food & Drug Administration (USFDA) to manufacture and market Flucytosine capsules, 250 mg and 500 mg.

RSS
First22852286228722882290229222932294Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR